Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash-to-Debt 3.60
HCHC's Cash-to-Debt is ranked higher than
72% of the 454 Companies
in the Global Telecom Services industry.

( Industry Median: 0.44 vs. HCHC: 3.60 )
Ranked among companies with meaningful Cash-to-Debt only.
HCHC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.06  Med: 0.21 Max: No Debt
Current: 3.6
Equity-to-Asset 0.02
HCHC's Equity-to-Asset is ranked lower than
92% of the 453 Companies
in the Global Telecom Services industry.

( Industry Median: 0.41 vs. HCHC: 0.02 )
Ranked among companies with meaningful Equity-to-Asset only.
HCHC' s Equity-to-Asset Range Over the Past 10 Years
Min: -1.46  Med: 0.07 Max: 0.65
Current: 0.02
-1.46
0.65
Interest Coverage 0.39
HCHC's Interest Coverage is ranked lower than
99.99% of the 370 Companies
in the Global Telecom Services industry.

( Industry Median: 7.30 vs. HCHC: 0.39 )
Ranked among companies with meaningful Interest Coverage only.
HCHC' s Interest Coverage Range Over the Past 10 Years
Min: 0.02  Med: 0.62 Max: 1.08
Current: 0.39
0.02
1.08
Piotroski F-Score: 6
Altman Z-Score: 0.40
Beneish M-Score: -2.75
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 1.14
HCHC's Operating Margin % is ranked lower than
74% of the 453 Companies
in the Global Telecom Services industry.

( Industry Median: 7.70 vs. HCHC: 1.14 )
Ranked among companies with meaningful Operating Margin % only.
HCHC' s Operating Margin % Range Over the Past 10 Years
Min: -17.13  Med: -1.09 Max: 4.44
Current: 1.14
-17.13
4.44
Net Margin % -4.86
HCHC's Net Margin % is ranked lower than
77% of the 455 Companies
in the Global Telecom Services industry.

( Industry Median: 3.68 vs. HCHC: -4.86 )
Ranked among companies with meaningful Net Margin % only.
HCHC' s Net Margin % Range Over the Past 10 Years
Min: -9.4  Med: -2.71 Max: 62.65
Current: -4.86
-9.4
62.65
ROE % -95.77
HCHC's ROE % is ranked lower than
96% of the 437 Companies
in the Global Telecom Services industry.

( Industry Median: 6.20 vs. HCHC: -95.77 )
Ranked among companies with meaningful ROE % only.
HCHC' s ROE % Range Over the Past 10 Years
Min: -152.48  Med: -24.61 Max: 181.6
Current: -95.77
-152.48
181.6
ROA % -2.77
HCHC's ROA % is ranked lower than
77% of the 462 Companies
in the Global Telecom Services industry.

( Industry Median: 2.38 vs. HCHC: -2.77 )
Ranked among companies with meaningful ROA % only.
HCHC' s ROA % Range Over the Past 10 Years
Min: -7.32  Med: -2.73 Max: 107.47
Current: -2.77
-7.32
107.47
ROC (Joel Greenblatt) % 9.48
HCHC's ROC (Joel Greenblatt) % is ranked lower than
75% of the 458 Companies
in the Global Telecom Services industry.

( Industry Median: 14.31 vs. HCHC: 9.48 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HCHC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -48.88  Med: -6.22 Max: 379.03
Current: 9.48
-48.88
379.03
3-Year Revenue Growth Rate 36.60
HCHC's 3-Year Revenue Growth Rate is ranked higher than
95% of the 399 Companies
in the Global Telecom Services industry.

( Industry Median: 2.40 vs. HCHC: 36.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HCHC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -32.6  Med: -3.25 Max: 85.3
Current: 36.6
-32.6
85.3
3-Year EPS without NRI Growth Rate 31.30
HCHC's 3-Year EPS without NRI Growth Rate is ranked higher than
87% of the 289 Companies
in the Global Telecom Services industry.

( Industry Median: -2.60 vs. HCHC: 31.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HCHC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -78.4  Med: 4.35 Max: 181
Current: 31.3
-78.4
181
GuruFocus has detected 2 Warning Signs with HC2 Holdings Inc $HCHC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HCHC's 30-Y Financials

Financials (Next Earnings Date: 2017-08-10 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with HCHC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of HC2 Holdings Inc

SymbolPriceYieldDescription
HCCDZ0.000.008 1/8 %Cum Conv Perp Pfd Shs Series -A-2- -144A-

Business Description

Industry: Communication Services » Telecom Services    NAICS: 517110    SIC: 4813
Compare:NYSE:OOMA, NAS:IGLD, OTCPK:MTENY, NAS:HCOM, NAS:PDVW, NAS:SIFY, NAS:CALL, NAS:SPOK, NAS:ALSK, NYSE:I, NAS:SITO, NYSE:NTL, NAS:IPAS, NAS:SONS, NAS:UTSI, NAS:FRP, NYSE:IDT, OTCPK:BVWN, OTCPK:NULM, NAS:NIHD » details
Traded in other countries:PSTA.Germany,
Headquarter Location:USA
HC2 Holdings Inc is a diversified holding company with seven reportable operating segments which includes Construction, Marine Services, Energy, Telecommunications, Life Sciences, Insurance and Other.

HC2 Holdings Inc, formerly PTGi Holding Inc, was formed as a corporation under the laws of Delaware in 1994 and operates as a holding company of operating subsidiaries mainly in the United States and the United Kingdom. The Company operates a network of direct routes. It provides premium voice communication services for national telecom operators, mobile operators, wholesale carriers, prepaid operators, Voice over Internet Protocol service operators and Internet service providers. The Company classifies its services into two categories: Traditional Services and International Carrier Services and has provided these services from its two business units: North America Telecom and ICS. The Company manages its Traditional Services, which includes its domestic and international long-distance voice, local landline services, prepaid cards, and dial-up Internet services; and its International Carrier Services, particularly in its main markets of Asia Pacific, Latin America, North America/Canada/Mexico and Europe/Middle East/Asia. The Company is subject to varying degrees of regulation in each of the jurisdictions in which it operates.

Top Ranked Articles about HC2 Holdings Inc

HC2 Holdings to Participate at the B. Riley 18th Annual Investor Conference
DBM Global Inc., an HC2 Portfolio Company, to Move Up Payment of Previously Announced Cash Dividend
DBM Global Moves Up Dividend Payment Date From June 5, 2017 to May 30, 2017
HC2 Holdings Announces Transfer of Listing From NYSE MKT to the New York Stock Exchange
DBM Global Inc., an HC2 Portfolio Company, to Pay Cash Dividend
DBM Global to Pay Cash Dividend
HC2 Holdings, Inc. Sets First Quarter 2017 Earnings Release Date and Webcast
Early Warning – National Instrument 62-103- The Early Warning System and Related Take-Over Bid and Insider Reporting Issues
HC2 Portfolio Company MEDIBEACON™ Inc. Completes Successful Clinical Study of Groundbreaking Kidney Function Monitor

NEW YORK, March 02, 2017 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) ( MKT:HCHC), a diversified holding company, announced today that MediBeacon Inc., a portfolio company within HC2’s Pansend Life Sciences subsidiary, successfully completed a real-time, point of care renal function clinical study on subjects with impaired kidney function at Washington University in St. Louis.  During the Pilot Two study, kidney function was measured in subjects ranging from normal to impaired Stage 4 Chronic Kidney Disease (CKD). The study also included subjects at St. Louis University Hospital.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/daa7caaf-6c7f-421b-af21-8df3a0bf3883 “We are extremely excited by the continued progress MediBeacon has made in validating their technology,” said Phil Falcone, HC2’s Chairman, Chief Executive Officer and President.  “This is a significant milestone that further reinforces our confidence in our investment in MediBeacon and its ability to use innovative technology to improve patient care and reduce costs to the healthcare system.” MediBeacon’s proposed Transdermal Glomerular Filtration Rate (“GFR”) Monitor uses an optical skin sensor combined with a proprietary fluorescent tracer agent that glows in the presence of light.  The system has been designed to provide clinicians continuous real-time monitoring of kidney function with no need for blood sampling. “Completion of our Pilot Two study on patients with impaired kidney function represents an important milestone,” said Steve Hanley, MediBeacon CEO.  “We anticipate beginning our multicenter clinical study including sites in the United States and Europe during the fourth quarter 2017.” Blood samples taken in clinical practice today provide only time-delayed estimates and suffer from variability that may lead to inaccuracies. “Methods to assess kidney function have not changed in 25 years,” said Dr. Richard Solomon, Patrick Professor of Medicine and Director, Division of Nephrology and Hypertension at The University of Vermont College of Medicine. “MediBeacon’s point of care system could represent a major breakthrough in measuring kidney function.” Other Recent Developments Current MediBeacon technology applications are being investigated in the fields of kidney health, gastrointestinal permeability and optical angiography. The company’s Intellectual Property (IP) portfolio has grown to 29 granted U.S. patents, with 17 pending patent applications. In September 2016, MediBeacon was awarded a grant from the National Eye Institute (NEI) of the National Institutes of Health (NIH) under Award Number R43EY027207.  With this support, the company is pursuing research into the use of a MediBeacon fluorescent tracer agent to visualize vasculature in the eye. In October 2016, MediBeacon, in collaboration with Washington University, was awarded a $1.1 million grant from the Bill & Melinda Gates Foundation for a research project aimed at improving the understanding of childhood malnutrition and its related problems, including stunted growth. About HC2 HC2 Holdings, Inc. is a publicly traded ( MKT:HCHC) diversified holding company, which seeks opportunities to acquire and grow businesses that can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders. HC2 has a diverse array of operating subsidiaries across seven reportable segments, including Manufacturing, Marine Services, Utilities, Telecommunications, Life Sciences, Insurance and Other. HC2's largest operating subsidiaries include DBM Global Inc., a family of companies providing fully integrated structural and steel construction services, and Global Marine Systems Limited, a leading provider of engineering and underwater services on submarine cables. Founded in 1994, HC2 is headquartered in New York, New York. Learn more about HC2 and its portfolio companies at www.hc2.com About MediBeacon Inc. MediBeacon’s mission is to commercialize biocompatible optical diagnostic agents for physiological monitoring, surgical guidance, and imaging of pathological disease in the human population. Several product concepts in these arenas are contained in the MediBeacon Intellectual Property estate. MediBeacon’s portfolio includes a renal function system that uses an optical skin sensor combined with a proprietary fluorescent tracer agent that glows in the presence of light. This system, currently in human trials, provides clinicians continuous real-time monitoring of a patient’s kidney function. Learn more about MediBeacon at www.medibeacon.com Cautionary Statement Regarding Forward-Looking Statements Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995: This release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements, including statements regarding the commencement or completion of the offering. Generally, forward-looking statements include information describing the offering and other actions, events, results, strategies and expectations and are generally identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. The forward-looking statements in this press release include, without limitation, statements regarding our expectation regarding building shareholder value.  Such statements are based on the beliefs and assumptions of HC2’s management and the management of HC2’s subsidiaries and portfolio companies. The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and the Company’s actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent reports on Forms 10-K, 10-Q and 8-K. Such important factors include, without limitation, the ability of our subsidiaries (including, target businesses following their acquisition) to generate sufficient net income and cash flows to make upstream cash distributions, capital market conditions, our and our subsidiaries’ ability to identify any suitable future acquisition opportunities, efficiencies/cost avoidance, cost savings, income and margins, growth, economies of scale, combined operations, future economic performance, conditions to, and the timetable for, completing the integration of financial reporting of acquired or target businesses with HC2 or the applicable subsidiary of HC2, completing future acquisitions and dispositions, litigation, potential and contingent liabilities, management’s plans, changes in regulations and taxes. These risks and other important factors discussed under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”), and our other reports filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. You should not place undue reliance on forward-looking statements. All forward-looking statements attributable to HC2 or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made, and HC2 undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise. The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
For information on HC2 Holdings, Inc., please contact:

Andrew G. Backman
Managing Director
Investor Relations & Public Relations
[email protected]
212-339-5836

Read more...

Ratios

vs
industry
vs
history
Price-to-Owner-Earnings 3.91
HCHC's Price-to-Owner-Earnings is ranked higher than
59% of the 229 Companies
in the Global Telecom Services industry.

( Industry Median: 17.50 vs. HCHC: 3.91 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HCHC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 0.41  Med: 2.27 Max: 17.58
Current: 3.91
0.41
17.58
PB Ratio 5.07
HCHC's PB Ratio is ranked lower than
86% of the 439 Companies
in the Global Telecom Services industry.

( Industry Median: 2.23 vs. HCHC: 5.07 )
Ranked among companies with meaningful PB Ratio only.
HCHC' s PB Ratio Range Over the Past 10 Years
Min: 0.28  Med: 1.71 Max: 7.62
Current: 5.07
0.28
7.62
PS Ratio 0.13
HCHC's PS Ratio is ranked higher than
97% of the 449 Companies
in the Global Telecom Services industry.

( Industry Median: 1.47 vs. HCHC: 0.13 )
Ranked among companies with meaningful PS Ratio only.
HCHC' s PS Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.25 Max: 36.83
Current: 0.13
0.08
36.83
Price-to-Free-Cash-Flow 3.36
HCHC's Price-to-Free-Cash-Flow is ranked higher than
93% of the 227 Companies
in the Global Telecom Services industry.

( Industry Median: 18.35 vs. HCHC: 3.36 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HCHC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 2.78  Med: 12.6 Max: 123.53
Current: 3.36
2.78
123.53
Price-to-Operating-Cash-Flow 2.18
HCHC's Price-to-Operating-Cash-Flow is ranked higher than
89% of the 312 Companies
in the Global Telecom Services industry.

( Industry Median: 7.08 vs. HCHC: 2.18 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HCHC' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.55  Med: 4.03 Max: 45
Current: 2.18
1.55
45
EV-to-EBIT -36.79
HCHC's EV-to-EBIT is ranked lower than
99% of the 717 Companies
in the Global Telecom Services industry.

( Industry Median: 13.99 vs. HCHC: -36.79 )
Ranked among companies with meaningful EV-to-EBIT only.
HCHC' s EV-to-EBIT Range Over the Past 10 Years
Min: -109.8  Med: -5.4 Max: 368.7
Current: -36.79
-109.8
368.7
EV-to-EBITDA -16.54
HCHC's EV-to-EBITDA is ranked lower than
99.99% of the 751 Companies
in the Global Telecom Services industry.

( Industry Median: 7.67 vs. HCHC: -16.54 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCHC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -206  Med: -2.5 Max: 111.9
Current: -16.54
-206
111.9
Shiller PE Ratio 52.28
HCHC's Shiller PE Ratio is ranked lower than
82% of the 115 Companies
in the Global Telecom Services industry.

( Industry Median: 17.93 vs. HCHC: 52.28 )
Ranked among companies with meaningful Shiller PE Ratio only.
HCHC' s Shiller PE Ratio Range Over the Past 10 Years
Min: 8.47  Med: 32.46 Max: 133.33
Current: 52.28
8.47
133.33
Current Ratio 0.83
HCHC's Current Ratio is ranked lower than
65% of the 440 Companies
in the Global Telecom Services industry.

( Industry Median: 1.09 vs. HCHC: 0.83 )
Ranked among companies with meaningful Current Ratio only.
HCHC' s Current Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.98 Max: 3.02
Current: 0.83
0.2
3.02
Quick Ratio 0.83
HCHC's Quick Ratio is ranked lower than
61% of the 440 Companies
in the Global Telecom Services industry.

( Industry Median: 1.01 vs. HCHC: 0.83 )
Ranked among companies with meaningful Quick Ratio only.
HCHC' s Quick Ratio Range Over the Past 10 Years
Min: 0.2  Med: 0.98 Max: 3.02
Current: 0.83
0.2
3.02
Days Inventory 2.96
HCHC's Days Inventory is ranked higher than
88% of the 345 Companies
in the Global Telecom Services industry.

( Industry Median: 16.41 vs. HCHC: 2.96 )
Ranked among companies with meaningful Days Inventory only.
HCHC' s Days Inventory Range Over the Past 10 Years
Min: 2.96  Med: 5.03 Max: 5.76
Current: 2.96
2.96
5.76
Days Sales Outstanding 43.62
HCHC's Days Sales Outstanding is ranked lower than
65% of the 347 Companies
in the Global Telecom Services industry.

( Industry Median: 47.59 vs. HCHC: 43.62 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCHC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.53  Med: 50.67 Max: 103.24
Current: 43.62
21.53
103.24
Days Payable 17.06
HCHC's Days Payable is ranked lower than
84% of the 292 Companies
in the Global Telecom Services industry.

( Industry Median: 65.46 vs. HCHC: 17.06 )
Ranked among companies with meaningful Days Payable only.
HCHC' s Days Payable Range Over the Past 10 Years
Min: 11.54  Med: 35.63 Max: 99.96
Current: 17.06
11.54
99.96

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -43.20
HCHC's 3-Year Average Share Buyback Ratio is ranked lower than
94% of the 271 Companies
in the Global Telecom Services industry.

( Industry Median: -1.60 vs. HCHC: -43.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCHC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -43.2  Med: -18.05 Max: 59
Current: -43.2
-43.2
59

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 19.21
HCHC's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
99.99% of the 220 Companies
in the Global Telecom Services industry.

( Industry Median: 1.43 vs. HCHC: 19.21 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HCHC' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0  Med: 4.14 Max: 19.64
Current: 19.21
0
19.64
Price-to-Median-PS-Value 0.53
HCHC's Price-to-Median-PS-Value is ranked higher than
89% of the 387 Companies
in the Global Telecom Services industry.

( Industry Median: 1.02 vs. HCHC: 0.53 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HCHC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0  Med: 0.95 Max: 177.17
Current: 0.53
0
177.17
Earnings Yield (Greenblatt) % -2.70
HCHC's Earnings Yield (Greenblatt) % is ranked lower than
86% of the 802 Companies
in the Global Telecom Services industry.

( Industry Median: 6.61 vs. HCHC: -2.70 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HCHC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -2.73  Med: 2.9 Max: 31737.9
Current: -2.7
-2.73
31737.9
Forward Rate of Return (Yacktman) % 46.90
HCHC's Forward Rate of Return (Yacktman) % is ranked higher than
94% of the 248 Companies
in the Global Telecom Services industry.

( Industry Median: 8.32 vs. HCHC: 46.90 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HCHC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -22.2  Med: 2.4 Max: 87.1
Current: 46.9
-22.2
87.1

More Statistics

Revenue (TTM) (Mil) $1,617
EPS (TTM) $ -2.30
Beta1.50
Short Percentage of Float3.55%
52-Week Range $3.80 - 7.27
Shares Outstanding (Mil)42.16
» More Articles for HCHC

Headlines

Articles On GuruFocus.com
HC2 Holdings to Participate at the B. Riley 18th Annual Investor Conference May 16 2017 
DBM Global Inc., an HC2 Portfolio Company, to Move Up Payment of Previously Announced Cash Dividend May 11 2017 
DBM Global Moves Up Dividend Payment Date From June 5, 2017 to May 30, 2017 May 11 2017 
HC2 Holdings Announces Transfer of Listing From NYSE MKT to the New York Stock Exchange May 10 2017 
DBM Global Inc., an HC2 Portfolio Company, to Pay Cash Dividend May 09 2017 
DBM Global to Pay Cash Dividend May 09 2017 
HC2 Holdings, Inc. Sets First Quarter 2017 Earnings Release Date and Webcast Apr 26 2017 
Early Warning – National Instrument 62-103- The Early Warning System and Related Take-Over Bid Apr 06 2017 
HC2 Portfolio Company MEDIBEACON™ Inc. Completes Successful Clinical Study of Groundbreaking K Mar 02 2017 
HC2's Life Sciences Subsidiary, Pansend LLC, Enters Into Agreement With MediBeacon to Bring Breakthr Aug 26 2015 

More From Other Websites
Edited Transcript of HCHC earnings conference call or presentation 10-May-17 9:00pm GMT May 17 2017
HC2 Holdings to Participate at the B. Riley 18th Annual Investor Conference May 16 2017
DBM Global Inc., an HC2 Portfolio Company, to Move Up Payment of Previously Announced Cash Dividend May 11 2017
DBM Global Moves Up Dividend Payment Date From June 5, 2017 to May 30, 2017 May 11 2017
HC2 Holdings reports 1Q loss May 10 2017
HC2 Holdings Reports First Quarter 2017 Results May 10 2017
HC2 Holdings Announces Transfer of Listing From NYSE MKT to the New York Stock Exchange May 10 2017
DBM Global Inc., an HC2 Portfolio Company, to Pay Cash Dividend May 09 2017
HC2 Holdings, Inc. Sets First Quarter 2017 Earnings Release Date and Webcast Apr 26 2017
BeneVir Granted Patent Protecting Lead Oncolytic Immunotherapy Stealth-1H and Other Platform Assets Apr 25 2017
Early Warning – National Instrument 62-103- The Early Warning System and Related Take-Over Bid and... Apr 06 2017
ETFs with exposure to HC2 Holdings, Inc. : April 5, 2017 Apr 05 2017
HC2 Holdings, Inc. :HCHC-US: Earnings Analysis: Q4, 2016 By the Numbers : March 22, 2017 Mar 22 2017
HC2 Holdings, Inc. :HCHC-US: Earnings Analysis: 2016 By the Numbers : March 21, 2017 Mar 21 2017
Edited Transcript of HCHC earnings conference call or presentation 8-Mar-17 10:00pm GMT Mar 10 2017
HC2 Holdings Reports Fourth Quarter and Full Year 2016 Results Mar 08 2017
HC2 Portfolio Company MEDIBEACON™ Inc. Completes Successful Clinical Study of Groundbreaking... Mar 02 2017
MediBeacon™ Inc. Completes Successful Clinical Study of Transdermal Glomerular Filtration Rate... Mar 02 2017
HC2 Holdings, Inc. Sets Fourth Quarter and Fiscal Year 2016 Earnings Release Date and Webcast Feb 27 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)